1,023
Views
32
CrossRef citations to date
0
Altmetric
Commentary

New Psychoactive Substances (NPS) – the Hydra monster of recreational drugs

&
Pages 1-3 | Received 16 Jul 2016, Accepted 20 Jul 2016, Published online: 23 Aug 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Lisa Franzén, Olof Beck & Anders Helander. (2019) An analytically confirmed non-fatal intoxication by carfentanil in Sweden. Clinical Toxicology 57:5, pages 372-374.
Read now
Matilda Bäckberg, Madeleine Pettersson Bergstrand, Olof Beck & Anders Helander. (2019) Occurrence and time course of NPS benzodiazepines in Sweden – results from intoxication cases in the STRIDA project. Clinical Toxicology 57:3, pages 203-212.
Read now
Olof Beck, Matilda Bäckberg, Patrick Signell & Anders Helander. (2018) Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats. Clinical Toxicology 56:4, pages 256-263.
Read now
Anders Helander, Matilda Bäckberg, Patrick Signell & Olof Beck. (2017) Intoxications involving acrylfentanyl and other novel designer fentanyls – results from the Swedish STRIDA project. Clinical Toxicology 55:6, pages 589-599.
Read now

Articles from other publishers (28)

Ryoichi Fujiwara, Megan Journey, Fatimah Al-Doori, Paris Bell, Brahmjot Judge, Kamille Miracle, Kousei Ito & Sabrina Jones. (2023) Potential neonatal toxicity of new psychoactive substances. Pharmacology & Therapeutics 248, pages 108468.
Crossref
Hawraa Sameer Sajwani. (2023) The dilemma of new psychoactive substances: A growing threat. Saudi Pharmaceutical Journal 31:3, pages 348-350.
Crossref
Andrii Puzyrenko, Dan Wang, Randy Schneider, Greg Wallace, Sara Schreiber, Kristen Brandt & Ian L Gunsolus. (2022) Urine Drug Screening in the Era of Designer Benzodiazepines: Comparison of Three Immunoassay Platforms, LC–QTOF-MS and LC–MS-MS. Journal of Analytical Toxicology 46:7, pages 712-718.
Crossref
Amanda L A Mohr, Barry K Logan, Melissa F Fogarty, Alex J Krotulski, Donna M Papsun, Sherri L Kacinko, Marilyn A Huestis & Jeri D Ropero-Miller. (2022) Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review. Journal of Analytical Toxicology 46:6, pages e116-e185.
Crossref
Joshua Bloom, Mary Ann Howland & Emily T. Cohen. (2022) Reflections on Aspirin Toxicity: Interpreting Effects of Sodium Bicarbonate and Activated Charcoal. Journal of Medical Toxicology 18:2, pages 172-173.
Crossref
Chih-Huei Chiang, Chiu-Mieh Huang, Jiunn-Jye Sheu, Jung-Yu Liao, Hsiao-Pei Hsu, Shih-Wen Wang & Jong-Long Guo. (2021) Examining the Effectiveness of 3D Virtual Reality Training on Problem-solving, Self-efficacy, and Teamwork Among Inexperienced Volunteers Helping With Drug Use Prevention: Randomized Controlled Trial. Journal of Medical Internet Research 23:11, pages e29862.
Crossref
Bronislav Jurásek, Ivan Čmelo, Jan Svoboda, Jan Čejka, Daniel Svozil & Martin Kuchař. (2020) New psychoactive substances on dark web markets: From deal solicitation to forensic analysis of purchased substances. Drug Testing and Analysis 13:1, pages 156-168.
Crossref
Kwaku Kyei-Baffour & Craig W. Lindsley. (2020) DARK Classics in Chemical Neuroscience: U-47700 . ACS Chemical Neuroscience 11:23, pages 3928-3936.
Crossref
Michael H. Baumann, Graziella Tocco, Donna M. Papsun, Amanda L. Mohr, Melissa F. Fogarty & Alex J. Krotulski. (2020) U-47700 and Its Analogs: Non-Fentanyl Synthetic Opioids Impacting the Recreational Drug Market. Brain Sciences 10:11, pages 895.
Crossref
Zi-Ling Li, Zi-Yang Zhang, Teng-Wen Zhao, Chun-Yan Meng, Qian-Ying Zhang & Man-Man Wang. (2020) In-situ fabrication of zeolite imidazole framework@hydroxyapatite composite for dispersive solid-phase extraction of benzodiazepines and their determination with high-performance liquid chromatography-VWD detection. Microchimica Acta 187:9.
Crossref
Barak Shapira, Paola Rosca, Ronny Berkovitz, Igor Gorjaltsan & Yehuda Neumark. (2020) The switch from one substance-of-abuse to another: illicit drug substitution behaviors in a sample of high-risk drug users. PeerJ 8, pages e9461.
Crossref
Summon Chomchai, Jariya Phuditshinnapatra, Pattaraporn Mekavuthikul & Chulathida Chomchai. (2019) Effects of unconventional recreational drug use in pregnancy. Seminars in Fetal and Neonatal Medicine 24:2, pages 142-148.
Crossref
Paul J Jannetto, Anders Helander, Uttam Garg, Gregory C Janis, Bruce Goldberger & Hemamalini Ketha. (2019) The Fentanyl Epidemic and Evolution of Fentanyl Analogs in the United States and the European Union. Clinical Chemistry 65:2, pages 242-253.
Crossref
Madeleine Pettersson Bergstrand, Lilian H. J. Richter, Hans H. Maurer, Lea Wagmann & Markus R. Meyer. (2019) In vitro glucuronidation of designer benzodiazepines by human UDP-glucuronyltransferases . Drug Testing and Analysis 11:1, pages 45-50.
Crossref
Madeleine Pettersson Bergstrand, Olof Beck & Anders Helander. (2018) Urine analysis of 28 designer benzodiazepines by liquid chromatography–high-resolution mass spectrometry. Clinical Mass Spectrometry 10, pages 25-32.
Crossref
Emma Partridge, Stephen Trobbiani, Peter Stockham, Cheryl Charlwood & Chris Kostakis. (2018) A Case Study Involving U-47700, Diclazepam and Flubromazepam—Application of Retrospective Analysis of HRMS Data. Journal of Analytical Toxicology 42:9, pages 655-660.
Crossref
Janice Pettie, Allan Burt, Duleeka W. Knipe, Hazel Torrance, Margaret Dow, Karen Osinski, Robert Greig, Diletta Sabatini, Kate Easterford, James Dear & Michael Eddleston. (2018) New drug controls and reduced hospital presentations due to novel psychoactive substances in Edinburgh. British Journal of Clinical Pharmacology 84:10, pages 2303-2310.
Crossref
Anders Helander, Katarina Stojanovic, Tomas Villén & Olof Beck. (2018) Detectability of fentanyl and designer fentanyls in urine by 3 commercial fentanyl immunoassays. Drug Testing and Analysis 10:8, pages 1297-1304.
Crossref
Emma Partridge, Stephen Trobbiani, Peter Stockham, Timothy Scott & Chris Kostakis. (2018) A Validated Method for the Screening of 320 Forensically Significant Compounds in Blood by LC/QTOF, with Simultaneous Quantification of Selected Compounds. Journal of Analytical Toxicology 42:4, pages 220-231.
Crossref
María Luisa Soria. (2018) New psychoactive substances: Popular and dangerous. Spanish Journal of Legal Medicine 44:2, pages 64-72.
Crossref
María Luisa Soria. (2018) Las nuevas drogas psicoactivas: populares y peligrosas. Revista Española de Medicina Legal 44:2, pages 64-72.
Crossref
Evangelia Liakoni, Christopher Yates, Alison M. Dines, Paul I. Dargan, Fridtjof Heyerdahl, Knut Erik Hovda, David M. Wood, Florian Eyer & Matthias E. Liechti. (2018) Acute recreational drug toxicity. Medicine 97:5, pages e9784.
Crossref
Matilda Bäckberg, Karl-Henrik Jönsson, Olof Beck & Anders Helander. (2018) Investigation of drug products received for analysis in the Swedish STRIDA project on new psychoactive substances. Drug Testing and Analysis 10:2, pages 340-349.
Crossref
Jolanta B. Zawilska & Jakub Wojcieszak. 2018. Synthetic Cathinones. Synthetic Cathinones 11 24 .
Patrick M. Beardsley & Yan Zhang. 2018. New Psychoactive Substances. New Psychoactive Substances 353 381 .
Anders Helander & Matilda Bäckberg. 2018. New Psychoactive Substances. New Psychoactive Substances 461 473 .
Suzan S. Mazor. (2017) Pediatric Toxicology: An Ever Changing Field. Clinical Pediatric Emergency Medicine 18:3, pages 157-158.
Crossref
Davide Guerrieri, Emma Rapp, Markus Roman, Gunilla Thelander & Robert Kronstrand. (2017) Acrylfentanyl: Another new psychoactive drug with fatal consequences. Forensic Science International 277, pages e21-e29.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.